Comparison Between Magnetic Field and Laser Therapy in Management of Trigeminal Neuralgia

Delta University for Science and Technology

Status: Completed

Conditions: Trigeminal Neuralgia

Treatments: Other: Low level laser therapy (LLLT); Other: Electromagnetic therapy.

Study type: Interventional

Funder types: Other

Identifiers

NCT05075707

magnetic and laser therapy

Details and patient eligibility

About

Trigeminal neuralgia (TN) was defined by The International Association for the Study of Pain (IASP) as severe, sudden, usually unilateral, stabbing, brief, recurrent attacks of pain in one or more distributional branches of the trigeminal nerve. The purpose of the current study will to investigate the effect of Low level laser therapy versus electromagnetic therapy on diabetic trigeminal neuralgia pain intensity and amplitude of the compound muscle action potential of the masseter and temporalis muscles in diabetic TN patients.

Enrollment: 120 patients

Sex: All

Ages: 25 to 45 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• All participants will between the ages of 25 and 45, will of both sexes (male and female), diabetic type two patients with chronic trigeminal neuralgia, (from three to six months).
• Patients will awake, cooperative, and free of psychiatric issues (as determined by a psychologist) as well as difficulties resulting from orthopaedic or special sensory deficits.

Exclusion criteria

• Patients will ruled out if they developed TN due to a tumour, herpes zoster, or any other reason other than diabetes, such as significant coagulation dysfunction, cardiopulmonary dysfunction or previous invasive treatment (ethanol, radiofrequency, Gama-knife microvascular decompression, glycerinum injection).
• They will not have a previous disability in the face.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

120 participants in 3 patient groups

control group

No Intervention group

Description:

Participants will receive the descriptive medication by neurologist

electromagnetic group

Experimental group

Description:

Participants will receive the descriptive medication by neurologist in addition to electromagnetic therapy. Electromagnetic therapy will be applied for 20 min/session for three days each week for two months.

Treatment:

Other: Electromagnetic therapy.

low laser therapy group

Experimental group

Description:

Participants will receive the descriptive medication by neurologist in addition to low laser therapy. Low laser therapy will be applied for 20 min/session for three days each week for two months.

Treatment:

Other: Low level laser therapy (LLLT)